Carlos Sattler

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Suzanne M. Garland, Mauricio Hernández‐Ávila, Cosette M. Wheeler et al. · New England Journal of Medicine · 2007 · 1.9K citations

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A. Joura, Sepp Leodolter, Mauricio Hernández‐Ávila et al. · The Lancet · 2007 · 576 citations

Vaccination, L1 Virus-like-particle Vaccine, Vulvar Diseases +12

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

Stan L. Block, Terry Nolan, Carlos Sattler et al. · PEDIATRICS · 2006 · 480 citations

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

Carlos Sattler, Edward O. Mason, Sheldon L. Kaplan · The Pediatric Infectious Disease Journal · 2002 · 333 citations

Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old

Myron J. Levin, Anna‐Barbara Moscicki, Lin‐Ye Song et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 181 citations · Full text